机译:Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial
Department of Thoracic/Head and Neck Medical Oncology,The University of Texas MD Anderson Cancer;
Department of Biostatistics,The University of Texas MD Anderson Cancer Center;
Department of Pathology,The University of Texas MD Anderson Cancer CenterDepartment of Thoracic and Cardiovascular Surgery,The University of Texas MD Anderson Cancer CenterDepartment of Thoracic Imaging,The University of Texas MD Anderson Cancer CenterDepartment of Bioinformatics and Computational Biology,The University of Texas MD Anderson CancerThe Immunotherapy Platform,The University of Texas MD Anderson Cancer CenterDepartment of Translational Molecular Pathology,The University of Texas MD Anderson Cancer CenterPlatform for Innovative Microbiome and Translational Research (PRIME-TR), Department of Genomic;